#VisualAbstract: FOLFOX in combination with nivolumab and trastuzumab improves survival in metastatic ERBB2⁺ esophagogastric adenocarcinoma
Click to read this study in JAMA Oncology.
Click to read this study in JAMA Oncology.
Click to read the study in the European Journal of Cancer.
1. Overall survival and progression-free survival were higher for patients on nivolumab plus chemotherapy compared to chemotherapy alone. 2. Severe ...
1. While carcinoids contribute more heavily to the total incidence of early-onset colorectal cancer than they did in 2000, adenocarcinomas ...
Originally published by Harvard Health. What Is It? Adenocarcinoma of the lung is a type of lung cancer. It occurs ...
Image: PD 1. There was no difference in overall survival of patients with brain metastases from EGFR-mutant lung adenocarcinoma receiving ...
Image: PD 1. Compared to patients receiving surgery alone, patients undergoing chemoradiotherapy (CRT) prior to resection experience reduced local recurrence, ...
Image: PD 1. Among patients with cervical adenocarcinoma in situ (AIS), >85% of women were diagnosed subsequent to an abnormal ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.